Capital One Financial’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,021
| Closed | -$286K | – | 151 |
|
|
2021
Q4 | $286K | Sell |
4,021
-450
| -10% | -$32K | 0.03% | 152 |
|
|
2021
Q3 | $335K | Hold |
4,471
| – | – | 0.04% | 146 |
|
|
2021
Q2 | $346K | Sell |
4,471
-650
| -13% | -$50.3K | 0.04% | 147 |
|
|
2021
Q1 | $378K | Sell |
5,121
-1,488
| -23% | -$110K | 0.05% | 136 |
|
|
2020
Q4 | $463K | Sell |
6,609
-7,200
| -52% | -$504K | 0.06% | 125 |
|
|
2020
Q3 | $782K | Hold |
13,809
| – | – | 0.1% | 119 |
|
|
2020
Q2 | $805K | Hold |
13,809
| – | – | 0.11% | 142 |
|
|
2020
Q1 | $642K | Buy |
+13,809
| New | +$642K | 0.1% | 160 |
|